be_ixf;ym_202512 d_26; ct_50
NASDAQ:NFE charts & data provided by TradingView

Latest Insights on NFE

erratic biotech stocks This New Strategy Makes Sense of Biotechs’ Erratic Moves March 30, 2022 by Andrew Prince Investment Opportunities, Stocks, Winning Investor Daily I find one type of stock equal parts frustrating and fascinating — biotechs.
Machine Learning on Wall Street Machine Learning Takes Investing to the Next Level March 28, 2022 by Steve Fernandez Technology, Trading Strategies, Winning Investor Daily Despite its prominence on Wall Street, most retail investors have had no access to machine learning … until now.
Profit from Artificial Intelligence Boost Your Profits With AI and Machine Learning March 25, 2022 by Ian King Technology, Trading Strategies, Winning Investor Daily Artificial intelligence and machine learning are great tools for investing.
Ethereum 2022 Is the Year of Ethereum March 22, 2022 by Ian King Cryptocurrency, Winning Investor Daily Ethereum has yet to be toppled as the king of the hill.
Biotech Stocks Haven’t Been This Cheap Since March 2020 March 21, 2022 by Steve Fernandez Investment Opportunities, Stocks, Winning Investor Daily A big move is coming for biotech and pharmaceutical stocks.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

Share This